Name: UMIN ID:
Unique ID issued by UMIN | UMIN000041118 |
---|---|
Receipt number | R000046953 |
Scientific Title | Phase III study combined with post-marketing clinical study of RM1319 in patients with inborn errors of bile acid metabolism, including children |
Date of disclosure of the study information | 2020/07/15 |
Last modified on | 2023/09/11 11:31:24 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2020/07/15 18:49:57 | ||
2 | Update | 2022/06/14 11:46:26 | Key secondary outcomes Key secondary outcomes |
|
3 | Update | 2022/06/14 11:57:24 | Organization Organization Organization Organization Institute |
|
4 | Update | 2022/06/14 11:58:54 | Recruitment status Last follow-up date |
|
5 | Update | 2022/08/17 09:48:31 | Name of person sending information Name of person sending information |
|
6 | Update | 2023/09/11 11:28:06 | Co-sponsor Co-sponsor |
|
7 | Update | 2023/09/11 11:31:24 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |